Risperidone versus haloperidol in psychotic patients with disturbing neuroleptic-induced extrapyramidal symptoms: A double-blind, multi-center trial

Schizophrenia Research

Volumn 46, Issue 2-3, 2000, Pages 97-105

  Heck, A H ^a   Haffmans, P M J ^b   De Groot, I W ^a   Hoencamp, E ^b  

^a Psychiatric Center Zon and Schild   (Netherlands)

^b Stichting RBC   (Netherlands)

Author keywords

Antipsychotic; Extrapyramidal symptom; Haloperidol; Risperidone; Schizophrenia

Indexed keywords

HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYNDROME; HEADACHE; HUMAN; HYPERSALIVATION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PARKINSONISM; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RESTLESS LEGS SYNDROME; SCHIZOPHRENIA; SLEEP DISORDER; TREMOR; VOMITING;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; BRIEF PSYCHIATRIC RATING SCALE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; PSYCHOTIC DISORDERS; RISPERIDONE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX;

EID: 0034670622     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(00)00009-8     Document Type: Article

References (14)

1. Risperidone: clinical safety and efficacy in schizophrenia
2. Ethoprazine and benztropine in neuroleptic-induced parkinsonism
3. The extrapyramidal symptom rating scale
4. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
5. Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double-blind comparative study
6. 2 antagonistic properties
7. Symptoms in neuroleptic-naive first-episode schizophrenia: response to risperidone
8. Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone
9. A combined analysis of double-blind studies with risperidone vs. placebo and other antipsychotic agents: factors associated with extrapyramidal symptoms
10. The biochemical profile of risperidone, a new antipsychotic
11. Risperidone in the treatment of schizophrenia
12. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol
13. Neuroleptic dosing in chronic schizophrenia: a 10-year follow-up study
14. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding